Drug Type Immune cell therapy |
Synonyms AVB 003, AVB-003 |
Target |
Mechanism IL-15 modulators(Interleukin-15 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Avenge Bio, Inc.Startup |
Active Organization Avenge Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | US | Avenge Bio, Inc.Startup | 21 Jan 2022 |